BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page1of16
Research
RESEARCH
Effectiveness of telemonitoring integrated into existing
clinical services on hospital admission for exacerbation
of chronic obstructive pulmonary disease: researcher
blind, multicentre, randomised controlled trial
OPENACCESS
Hilary Pinnock reader1 , Janet Hanley principal research fellow2 , Lucy McCloughan programme
manager3 , Allison Todd research nurse3 , Ashma Krishan statistician4 , Stephanie Lewis reader in
medical statistics5 , Andrew Stoddart health economist6 , Marjon van der Pol professor of health
economics7 , William MacNee professor of respiratory and environmental medicine8 , Aziz Sheikh
professor of primary care research and development and directorHarkness fellow in healthcare
policyandpractice19 ,ClaudiaPagliariseniorlecturerinprimarycareandhealthinformatics3
,Brian
McKinstry professor of primary care ehealth3
1AllergyandRespiratoryResearchGroup,CentreforPopulationHealthSciences,UniversityofEdinburgh,EdinburghEH89AG,UK;2Schoolof
Nursing,MidwiferyandSocialCare,EdinburghNapierUniversity,Edinburgh,UK;3eHealthResearchGroup,CentreforPopulationHealthSciences,
Edinburgh,UK;4EdinburghClinicalTrialsUnit,UniversityofEdinburgh,UK;5CentreforPopulationHealthSciences,Edinburgh,UK;6HealthServices
ResearchUnit,UniversityofEdinburgh,UK;7HealthEconomicsResearchUnit,UniversityofAberdeen,Aberdeen,UK;8CentreforInflammation
Research,UniversityofEdinburgh,UK;9DivisionofGeneralInternalMedicineandPrimaryCare,BrighamandWomen’sHospital,HarvardMedical
School,Boston,MA,USA
Abstract MainoutcomemeasuresTheprimaryoutcomewastimetohospital
ObjectiveTotesttheeffectivenessoftelemonitoringintegratedinto admissionduetoCOPDexacerbationuptooneyearafterrandomisation.
existingclinicalservicessuchthatinterventionandcontrolgroupshave Otheroutcomesincludednumberanddurationofadmissions,and
accesstothesameclinicalcare. validatedquestionnaireassessmentsofhealthrelatedqualityoflife
(usingStGeorge’srespiratoryquestionnaire(SGRQ)),anxietyor DesignResearcherblind,multicentre,randomisedcontrolledtrial.
depression(orboth),selfefficacy,knowledge,andadherenceto
SettingUKprimarycare(Lothian,Scotland).
treatment.Analysiswasintentiontotreat.
ParticipantsAdultswithatleastoneadmissionforchronicobstructive
ResultsOf256patientscompletingthestudy,128patientswere
pulmonarydisease(COPD)intheyearbeforerandomisation.We
randomisedtotelemonitoringand128tousualcare;baseline
excludedpeoplewhohadothersignificantlungdisease,whowereunable
characteristicsofeachgroupweresimilar.Thenumberofdaysto
toprovideinformedconsentorcompletethestudy,orwhohadother
admissiondidnotdiffersignificantlybetweengroups(adjustedhazard
significantsocialorclinicalproblems.
ratio0.98,95%confidenceinterval0.66to1.44).Overoneyear,the
InterventionsParticipantswererecruitedbetween21May2009and meannumberofCOPDadmissionswassimilarinbothgroups
28March2011,andcentrallyrandomisedtoreceivetelemonitoringor (telemonitoring1.2admissionsperperson(standarddeviation1.9)v
conventionalselfmonitoring.Usingatouchscreen,telemonitoring control1.1(1.6);P=0.59).MeandurationofCOPDadmissionsoverone
participantsrecordedadailyquestionnaireaboutsymptomsand yearwasalsosimilarbetweengroups(9.5daysperperson(standard
treatmentuse,andmonitoredoxygensaturationusinglinkedinstruments. deviation19.1)v8.8days(15.9);P=0.88).Theinterventionhadno
Algorithms,basedonthesymptomscore,generatedalertsifreadings significanteffectonSGRQscoresbetweengroups(68.2(standard
wereomittedorbreachedthresholds.Bothgroupsreceivedsimilarcare deviation16.3)v67.3(17.3);adjustedmeandifference1.39(95%
fromexistingclinicalservices. confidenceinterval−1.57to4.35)),oronotherquestionnaireoutcomes.
Correspondence to: H Pinnock hilary.pinnock@ed.ac.uk
Extra material supplied by the author (see http://www.bmj.com/content/347/bmj.f6070?tab=related#webextra)
Web appendix: Supplementary material
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page2of16
RESEARCH
ConclusionsInparticipantswithahistoryofadmissionforexacerbations Participants
ofCOPD,telemonitoringwasnoteffectiveinpostponingadmissions
WerecruitedadultsregisteredwithLothiangeneralpractices
anddidnotimprovequalityoflife.Thepositiveeffectoftelemonitoring
whohadbeenadmittedtohospitalwithanexacerbationof
seeninprevioustrialscouldbeduetoenhancementoftheunderpinning
COPDinthepreviousyearandwhowerethusatriskoffuture
clinicalserviceratherthanthetelemonitoringcommunication. admissions.17Oureligibilitycriteriawereasinclusiveas
TrialregistrationISRCTN96634935. possible,includingpatientsofallagesandwitharangeof
Funding:ThetrialwasfundedbyanNHSappliedresearchprogramme
comorbidities.18Thus,weonlyexcludedpeoplewithother
grantfromtheChiefScientistOfficeoftheScottishgovernment significantlungdisease;whowereunabletoprovideinformed
(ARPG/07/03).Thefunderhadnoroleinstudydesignandthecollection, consent,usethetechnology,orcompletethequestionnaires;or,
analysis,andinterpretationofdataandthewritingofthearticleandthe ontheadviceoftheirgeneralpractitioner(GP),forother
decisiontosubmititforpublication.NHSLothiansupportedthe significantsocialorclinicalproblems.
telemonitoringserviceandtheclinicalservices.
Participant recruitment
Introduction
Weusedthreestrategiestoidentifypotentiallyeligible
Potentiallyaffectingoneinfouradultsbytheageof80years,1 participants.Communityrespiratoryandnursingteamsscreened
chronicobstructivepulmonarydisease(COPD)isalreadya theircaseloads.Respiratoryconsultantsidentifiedandcontacted
leadingcauseofdeathanddisabilityinhigh,middle,andlow potentiallyeligiblepatentsfromhospitaladmissiondatafrom
incomecountries.23Telemonitoringhasattractedinterestasa theInformationServicesDivision(www.isdscotland.org/).
potentialsolutiontotheglobalchallengeofprovidingcarefor Finally,supportedbytheScottishPrimaryCareResearch
ageingpopulationslivingwithlongtermconditionssuchas Network,96primarycarepracticessearchedforpatientsintheir
COPD,4leadingtoitsenthusiasticpromotionbypolicymakers.56 databases.WithGPagreement,theresponsiblecliniciansent
TherecentUKWholeSystemsDemonstrator(WSD)evaluation trialinformationtoalleligiblepatientsinvitingthemtoexpress
analysedacohortofpatientswithconditionsincludingCOPD, interestinparticipatinginthetrial.
diabetes,andheartfailure.7Thestudy’sfindingslendsome
Potentiallyinterestedparticipantswereinvited,withone
supporttotheassertionthataserviceredesignthatincluded reminder,toabaselineassessmentwitharesearchnurseintheir
telemonitoringcanreduceadmissionsandmortalityinpeople homeatleastsixweeksafterthemostrecentexacerbation
withlongtermconditions,althoughnotcosteffectively.8
(whetheranadmissionormanagedathome).Theresearchnurse
Despitecallsforrobusteffectivenesstrialsoftelemonitoringin providedfurtherinformationaboutthetrialandobtained
COPD,9fivesystematicreviewshavereportedinconclusive consent.DiagnosisofCOPDwasconfirmedbythepresenceof
results.10-14Patients’attitudesandreceptivenesstowardsthis chronicairflowlimitationonspirometrynormallyperformed
approachare“promising,”13buttheevidenceisinsufficientto atthebaselineassessmentbytheresearchnursetrainedin
drawfirmconclusionsaboutclinicaleffectiveness101213orcost spirometry.COPDwasconfirmedifthepost-bronchodilator
effectiveness.13Theheterogeneityofinterventionsthatuse forcedexpiratoryvolumeinonesecond(FEV)dividedbythe
1
telemonitoringcontributestothedifficultyininterpreting forcedvitalcapacitywaslessthan0.7.19Recordingsundertaken
outcomes—rangingfrom“simple”telephonefollow-uptodaily byaspecialistrespiratoryservicewithinthepreviousthree
telemonitoringofphysiologicalorsymptomscoresortomore monthswereacceptedifspirometryatthebaselineassessment
complextelemonitoringinterventionswithgreatlyenhanced wasnotpossibleordeclined.Allconsentingparticipantsmeeting
clinicalsupport.1014Thisheterogeneityhasledtocallsforfurther theeligibilitycriteriawereenrolledintothetrial.
researchtoclarifythespecificroleoftelemonitoring(asopposed
totheadditionalclinicalservicescreatedtosupportit)in Primary outcome measure
managingpeoplewithCOPD.10
Theprimaryaimoftheinterventionwastoreducethefrequency
Toinformtheongoingdebate,wedesignedastudyinwhich ofadmissions.Therefore,ourprimaryoutcomemeasurewas
telemonitoringwasintegratedintoexistingclinicalservices, thetimetofirsthospitaladmissionwithaprimarydiagnosisof
suchthatmonitoringwasprovidedbyclinicalteamswhoalready anexacerbationofCOPDuptoonecalendaryearafter
had(orwereabouttoassume)clinicalresponsibilityforthe randomisation.Wedefinedanexacerbationasasustained
patients.Bothinterventionandcontrolgroupshadaccesstothe worseningoftheparticipant’ssymptomsfromtheirusualstable
sameclinicalcare:theonlydifferencebetweenthegroupswas statethatwasbeyondnormalday-to-dayvariations,wasacute
theuseoftelemonitoring.15 inonset,andnecessitatedachangeintreatment.20An
exacerbationwasconsideredthe“primarydiagnosis”ifthe
Methods presentingsymptomswereconsistentwithandtheparticipant
wastreatedforanacuteexacerbationofCOPD,andifnoother
Weconducteda12month,researcherblinded,randomised
diseasewastreatedasapriority.
controlledtrialinprimarycareintheUnitedKingdom,which
recruitedparticipantsbetween21May2009and28March2011.
Secondary outcome measures
Adetailedprotocolhasbeenpublished.15Wedidnotmakeany
substantivechangestothetrialprocedures,butafterpilotwork,16 Fulldetailsofthesecondaryoutcomemeasuresareinthe
wemadesomeminorproceduralchangestoenhancerecruitment
publishedprotocol.15Briefly,wemeasuredthedifferenceofthe
andtostreamlinethecollectionofdatafromparticipants’ itemslistedintheboxatoneyearafterrandomisation.
healthcarerecords.Adetailedstatisticalanalysisplanwas
submittedtothetrialsponsorbeforecompletionofdata Baseline assessment
collection. Weundertookabaselineassessmentcomprisingcurrentsmoking
status,UKMedicalResearchCouncildyspnoeascore,26history
ofCOPD,presenceofcomorbidity,andbaselinequestionnaires.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page3of16
RESEARCH
Secondaryoutcomemeasures
Exacerbations,admissions,anddeaths
TimeuntilfirsthospitaladmissionwithanexacerbationofCOPDorallcausedeath
NumberanddurationofhospitaladmissionswithanexacerbationofCOPD;numberanddurationofadmissionsinwhichCOPDwasa
factor(forexample,listedasasignificantcomorbidity,orasanovernightadmissionforminorsurgerythatmightotherwisehavebeen
adaycase)
Numberanddurationofadmissionsforanycause
Numberofdeathsatoneyear
Numberofexacerbationsselfreportedbyparticipantsonquarterlyquestionnaires.Thisincludedallexacerbationstreatedwithsteroids
orantibiotics,whethercommencedbythepatient,primarycare,orsecondarycareincludingduringanadmission.
Questionnaireassessmentofhealthrelatedqualityoflife,anxietyanddepression,participantknowledge,andselfefficacy
andadherencewithtreatment
StGeorge’srespiratoryquestionnaire(SGRQ)21(bothmeandifferenceandproportionofparticipantswithscoresimprovingbythe
minimumclinicallyimportantdifference(definedasfourunits))
Hospitalanxietyanddepressionscale(HADS)22
Selfefficacyformanagingchronicdisease6itemscale(SECD6)23
Lunginformationneedsquestionnaire(LINQ)24
Medicationadherencereportscale(MARS).25
Healthcareresourceuse
Numberanddurationofcontacts(telephone,clinicvisits,orhomevisits)withcommunityservices
Randomisation and protection against bias clinicalteam(aspecialistrespiratoryteaminEdinburgh,anurse
specialistinlongtermconditionsinMidlothian,oratrained
Existingclinicalcarevariedinintensityandorganisation
callhandlerworkingwithgeneralpracticesforpatientsliving
throughoutthefourregionsofLothian.Therefore,consenting
inEastorWestLothian)monitoredthedailyonlinedata.
participantswerestratifiedbytheclinicalserviceproviding
Algorithms,basedonthesymptomscore,alertedtheclinical
theirexistingCOPDcare(seebelowforclinicalcare
monitoringteamifdailyreadingshadnotbeensubmittedorif
arrangements)andcentrallyrandomisedtoeithercontrolor
ascoreof4or5hadbeenrecorded(webappendix2).15
interventionwitha1:1allocationusingrandomisedblocksof
twoorfour.Thisprocesswasmanagedbythetelephone Theactiontakenwastheresponsibilityofthemonitoring
randomisationserviceoftheEdinburghClinicalTrialsUnit, clinicianwhonormallyknewthepatientandwasableto
ensuringconcealmentuntilthetreatmentwasassigned.The interpretthemonitoringdatainthelightofthepatient’shistory.29
researchnursephonedtherandomisationservice,informedthe Typically,thisinvolvedcontactingthepatientbytelephone
participantoftheallocation,andreferredintervention (althoughthesystemcouldsupportavideolink)andundertaking
participantsforinstallationofthetelemonitoringequipment. afurtherclinicalassessmenttoenableadecisionaboutfurther
Theresearchnurseresponsibleforfollow-upassessmentswas management(forexample,commencingrescuetreatment,a
differenttothenursewhoperformedrandomisation,anddata homevisit,immediateadmission,orreviewingthefollowing
entrywasundertakenbytrialadministratorsblindedto day).Althoughavideolinkwasavailable,poorreceptionmeant
allocation.Allprimaryoutcomeassessorswereblindtothe thatitwasonlyusedontwooccasions.Pulseoximetrydata
allocation. wereavailabletoinformtheclinicalassessment,andclinicians
wereabletodefinean“oxygensaturation”alertonanindividual
Trial intervention: telemonitoring patientbasis.
Figure1⇓illustratesthemodeloftelemonitoring.The
Control group
telemonitoringequipmentandsecurebroadbandlinkwas
installedinthehomesofinterventionparticipants.Theclinical Toensurethatourtrialspecificallytestedtheeffectofthe
teamresponsiblefortheircarethenvisitedtheparticipantat telemonitoringtechnology,interventionandcontrolgroupswere
hometoexplainhowtousethetechnologyandprovideself providedwiththesameclinicalcare(includingselfmanagement
managementeducation.Participantshadaccesstotechnological advice)accordingtotheregioninwhichtheylived(seebelow).
adviceandsupportthroughoutthetrial. Theonlydifferencebetweentheinterventionandcontrolgroups
wastheprovisionofthetelemonitoringservice.
Usingthetouchscreentelemonitoringequipment,theparticipant
recordedandtransmittedadailyquestionnaireaboutsymptoms
Clinical care in both groups
anduseoftreatment(webappendix1),andmonitoredoxygen
saturationusinglinkedvalidatedinstruments.Thesymptom ClinicalcareinbothgroupswasinaccordancewiththeLothian
scorewasbasedonvalidateddiarycards,28andthepatientwas protocols,whichwerebasedonnationalandinternational
askedtoassessiftheirdyspnoea,sputumpurulenceandvolume, guidelinerecommendations.1920Educationonselfmanagement
cough,wheezehadincreasedoriftheyhaddevelopedanupper ofexacerbationswasprovidedforallparticipants,reinforced
respiratorytractinfectionorhadafever.Theresponseswere byacopyoftheBritishLungFoundation’sbookletaboutliving
weightedasdescribedinthevalidationstudies:positiveanswers withCOPD,30whichincludesawrittenmanagementplan,and
tocardinalsymptomsofanexacerbationofCOPDscored2, anemergencysupplyofantibioticsandsteroidsweremade
theremainingquestionsscored1.28 available.
Thisinformationwassentbyasecureinternetconnectiontoa DifferentservicemodelsoperatedinthefourregionsofLothian.
passwordprotectedserverattheUK’shealthservice,which Adedicatedrespiratoryphysiotherapyservicewasavailable
wasaccessibletothesupportingclinicalteam.Thesupporting sevendaysaweekforparticipantsinthecityofEdinburgh.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page4of16
RESEARCH
Nursespecialistsinlongtermconditionsprovidedaweekday MultipleDeprivation),andnumberofpreviousadmissions.
serviceforparticipantsinthemixedurbanandruralpopulation Binaryoutcomeswereanalysedusinglogisticregressionand
ofMidlothian.InEastandWestLothian,carewasprovidedby continuousoutcomeswereanalysedusinggeneralisedlinear
theparticipants’registeredGP:telemonitoringdatawere models.However,forthemajorityoftheanalysesonnumber
monitoredbyatrainedadministrativeassistantwhoreferred anddurationofhospitaladmissions,aPoissondistribution
participantstotheirGPaccordingtothealgorithmusedinour functionwasusedowingtothedatabeingheavilyskewed,
pilotstudy(webappendix2).16Randomisationwasstratified adjustingforthestratificationvariableandpotential
bythesedifferentservicestoallowforthepossibilitythat confounders.Unadjustedanalyseswerealsoperformed.Where
outcomesmightnotbecomparableinthedifferentareas. appropriate,adjustmentsweremadeforbaselinemeasurements
usinganalysisofcovariance.
Data collection
Becausetheprimaryoutcomeandmajorityofthesecondary
Dataonadmissionswereextractedfromthehospitalrecordsat outcomeswereanalysedusingsurvivalanalysis,anymissing
theendofthetrial.Thenumberofadmissionsidentifiedwas datawerecensoredatthepointwhenthedatabecamemissing.
crossreferencedwiththeadmissionsreportedbythepatients Participantswhodiedwithouthavinghadanadmissionwitha
toensurethatwecapturedeventsoccurringawayfromthe primarydiagnosisofCOPDwerecensoredinthefinalanalysis.
patients’usualhospital.Thecauseoftheadmission(andthus Forotheranalyses,participantswithmissingdatawereomitted
whethertheeventcountedasaprimaryoutcome)wasassessed asnecessary.
independentlyfromthehospitaldischargesummarybyHPand
BMwithdisagreementsresolvedbydiscussion(withWM Subgroup analyses
arbitrating,ifnecessary).Questionnaireswereadministeredby Fortheprimaryoutcome,plannedsubgroupanalyseswere
aresearchnurseatahomevisitarrangedwithintwoweeksof performedbasedonage,sexseverity,presenceofany
thecalendaryearduringwhichtheparticipantwasinthetrial. comorbidity,andSGRQandHADscores,becausethesecould
Healthcareresourceusewascollectedbyquestionnaireposted behypothesisedtoaffecttheimpactoftheintervention.34
totheparticipantsthree,six,andninemonths(onereminder) Subgroupanalyseswereperformedbyaddingtheinteraction
andbytheresearchnurseatbaselineandthe12month betweenthesefactorsandtreatmentintothesurvivalanalysis
assessment.Healthcareresourceuseincludedconsultationswith modelandbyobservingwhetherthechangeinthemodellog
GPsandnurses,respiratoryandnursingteams,outofhours likelihoodwasstatisticallysignificant.Allanalyseswereagreed
services,emergencyservices,telephonecallstotheNHS24 apriori.Wedidnotplanorundertakeanyinterimanalysis.
healthinformationandselfcareadviceservice,andcoursesof
oralsteroidsandantibiotics.Therespiratoryphysiotherapy
Results
serviceinEdinburghandthenursesinMidlothianmaintained
detailedtimesheetsofallpatientcontacts.Alldatawereentered Recruitment
manuallyontothetrialdatabase,with10%checkedforaccuracy
Figure2⇓detailstheflowofparticipantsthroughthetrial.Of
byanexternalassessor.
422patientsidentifiedbyclinicalservices,theGPrefused
permissiontoapproachthreepatientsforsignificantclinicalor
Sample size calculations
socialreasons,leaving419whowerepotentiallyeligibleand
Weestimatedthat125participantsineacharmwouldallowus weresentaninvitationletterbytheclinicalteam.Ofthese,314
todetectadifferenceintheprimaryoutcomeoftimeto patientsexpressedaninterestinparticipatingand258provided
admissionfromamedianof200daysinthecontrolgroupto informedconsent.Twopatientswithdrewconsent(forpersonal
300daysintheinterventiongroup,with80%power,usinga reasons)beforerandomisation,sothat256wererandomised
significancelevelof5%(logranktest).Thisestimatewasbased equallybetweenthetwogroups.Twoparticipantswithdrew
ondatafromthelargeststudyoftelemonitoringavailableatthe theirconsentduringthecourseofthetrial(oneineachgroup).
time(n=155),whichshowedanincreaseinthetimetoadmission
fromamedianofabout200daysto400days.31Because Baseline characteristics
effectivenessinthattrialvariedbetweencentres,weoptedfor
Demographiccharacteristicsofparticipants,socialdeprivation,
aconservativeestimateofeffectsize.Toallowfor10%
markersofdiseaseseverity(includingadmissionsintheprevious
withdrawalfromfollow-upand7%ofdeathsoccurringbefore
year),presenceofcomorbidities,smokingstatus,andbaseline
admissiontohospitalwithCOPD,weincreasedourtarget
questionnairescoresweresimilarinbothgroups.However,
recruitmentto150perarm.Wemonitoredwithdrawalsand
slightlyfewerpatientsintheinterventiongroupthaninthe
deathsbeforeadmissionwithanexacerbationofCOPD,which
controlgrouphadoneormorecomorbidconditions(61%v
provedconsiderablylowerthanourestimates,enablingusto
71%;table1⇓).Thedemographicprofileoftheparticipants
stoprecruitmentat128participantsineachgroup.
(meanage69.4(standarddeviation8.6)years;45%male)was
similartothatofthepopulationreferredbytheirclinicianas
Data analysis
potentiallyeligibleandwillingfortheircontactdetailstobe
Allparticipantswhowererandomisedwerefollowedupand passedtotheresearchteam(69.8(9.1)years;43%).
includedintheanalysisintheirallocatedtreatmentgroups
regardlessofthetreatmentactuallyreceived(intentiontotreat Hospital admission with an exacerbation of
analysis).SurvivaldatawerepresentedusingKaplan-Meier COPD
curves,32analysedusingCoxproportionalhazardsmodels33
Themediantimetothefirsthospitaladmissionwithan
adjustingforpotentiallyimportantconfounders.These
exacerbationofCOPDwas362days(interquartilerange131
confounderswereservice(stratificationvariable),age,sex,
to>365)inthetelemonitoringgroupand361days(113to>365;
severity(post-bronchodilatorFEV%predicted),current
1 fig3⇓)inthecontrolgroup.Therewasnosignificantdifference
smokingstatus,presenceofcomorbidity,SGRQscore,HADS
inthehazardratioforadmissioninthetelemonitoringgroup
score,socialclass(basedonpostcodeandtheScottishIndexof
comparedwiththecontrolgroup(adjustedhazardratio0.98
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page5of16
RESEARCH
(95%confidenceinterval0.66to1.44)).Similarly,therewas representedanaverageof25contactsperpatientovertheyear
nosignificantdifferenceinthenumberofadmissionswithan ofthetrial—aboutonecontacteverytwoweeks,inadditionto
exacerbationofCOPD,orthetotalnumberofdaysspentin the510telephonecallsand821homevisitstotelemonitored
hospital(table2⇓).Unadjustedresults(datanotshown)were patientsthatwerenotdirectlyassociatedwithalerts.The92
similartotheadjustedanalyses. patientsinthecontrolgroupreceivedfewertelephonecallsand
FourdeathsoccurredbeforeadmissiontohospitalwithCOPD homevisitsthanthoseinthetelemonitoringgroup(353and
(oneinthetelemonitoringgroup)andwerecensoredinthe 681,respectively).
primaryanalysis.Usingacompositeoutcomeoftimetofirst
Subgroup analyses
COPDadmissionorallcausedeath,theadjustedhazardratio
foradmissioninthetelemonitoringgroupwas0.87(95% Figure4⇓showsthesubgroupanalyses.Theonlysignificant
confidenceinterval0.61to1.26)comparedwiththecontrol resultwasthattheinterventionwaslesseffectiveforparticipants
group. withmildormoderateCOPDthanforthosewithsevereorvery
severeCOPD.Althoughthiswasanapriorianalysis,severity
SelfreportedCOPDexacerbations,allcause wasoneofsevensubgroupstestedandwasbasedonasmall
admissions, and deaths numberofpatientsinthemildormoderategroup;therefore,it
Thetelemonitoringgroupshowedanon-significantincreasein issubjecttoconsiderableuncertainty.
thenumberofselfreportedexacerbationsperpatientduringthe
calendaryearcomparedwithcontrols(mean15.0(standard Discussion
deviation12.7)v12.8(11.8);adjustedmeandifference2.29
Inparticipantswitharecenthistoryofadmissionfor
(95%confidenceinterval−0.78to5.37)).Aselfreported
exacerbationsofCOPD,telemonitoringoveroneyeardidnot
exacerbationwasdefinedasapatientreportofanepisodeof
haveasignificantbenefitontimetoahospitaladmission,
takingantibioticsorsteroids.Thenumberanddurationof
durationofadmissions,orhealthrelatedqualityoflifewhen
admissionsforwhichanexacerbationwasnottheprimarycause
bothinterventionandcontrolgroupshadaccesstothesame
weresimilarinbothgroups(table2).Thenumberofdeathsdid
clinicalcare.Furthermore,telemonitoringwasassociatedwith
notdiffersignificantlybetweenthetelemonitoringandcontrol
alargeincreaseinthenumberoftelephoneconsultationsand
groups(16v21;adjustedoddsratio0.66(95%confidence
homevisits,andanon-significantincreaseinparticipant
interval0.29to1.48)).
reportedexacerbations.Telemonitoringthusdidnotrepresent
aneffectiveuseofNHSresources.
Questionnaire responses
Therewasnosignificantdifferencebetweenthegroupsinany Strengths and limitations
ofthequestionnairescores,andnodifferencesfrombaselineto
Ourresearcherblindedpragmatictrial,whichbuiltonrelevant
oneyearineithergroup.Theinterventionmadenosignificant
conceptualandsystematicreviewwork,1015reportsclinical
differencetohealthrelatedqualityoflifethetelemonitoring
effectivenessandworkloadimplicationsoftelemonitoringfor
andcontrolgroups(meanSGRQscoreatoneyear,68.2
COPD.Weobtainedtheprimaryoutcomedatafromtheclinical
(standarddeviation16.3)v67.3(17.3);adjustedmeandifference
recordsofallbuttwoparticipants,andthusachievedourtarget
1.39(95%confidenceinterval−1.57to4.35)),anxietyor
samplesize.Therewassomeattritionofquestionnaire
depression,selfefficacy,knowledge,oradherencetotreatment
completion,principallybecauseofdeathsduringthetrialyear,
(table3⇓).TheproportionofparticipantswhoseSGRQ20score
andbecauseseveralparticipantsfeltitwastooburdensome
improvedbymorethanfourunits(theminimumclinically
giventheirstateofhealthatthetime.
importantdifference)was25%inthetelemonitoringarmand
25%inthecontrolgroup. Theconfidenceintervalsforourprimaryoutcomewerewide
(0.66to1.44)andwecannotbeconfidentofrulingouta
Installation of telemonitoring equipment, clinicallymeaningfuldifferencethatwassmallerthantheone
training, and withdrawals wewerepoweredtostudy.Ouradmissionrelatedsecondary
outcomes,however,similarlyshowednosignificanteffect.Our
Table4⇓detailsthelogisticsofinstallingandtraining samplesizewasbasedonastudyconductedadecadeago.31
participantstousetheequipmentandreasonsforwithdrawals.
However,intheinterveningyears,therehasbeenaconsiderable
Themeantimefromrandomisationtocommencingmonitoring
drivetoreducethenumberanddurationofadmissions
was79days(standarddeviation48days),withnearlythree
(includingthedevelopmentofcommunityrespiratoryteams
quartersofthedelayrelatedtotheinstallationofadedicated
whoprovidedclinicalcareforthemajorityofourparticipants),
broadbandlineandsettingupofthetelemonitoringequipment.
thuslimitingthepotentialforfurtherreduction.
Of128participantsallocatedtotelemonitoring,113hadthe
Weensuredthatbothgroupshadaccesstothesameclinical
equipmentsuccessfullyinstalledand109completedtraining.
care,whichinourUKsettingwasfacilitatedbytheavailability
Eightparticipantswithdrewfromtelemonitoringduringthe
ofestablishedcommunityspecialistrespiratoryteams,specialist
trial,mostlybecauseofchangesinclinicalcircumstances.
nursesforlongtermconditions,orprimarycareteams.The
clinicalservicesintowhichthetelemonitoringwasintegrated
Contacts with clinical monitoring teams
variedbetweenthefourLothianregions,whichmayhave
Table5⇓detailsthecontactswithhealthcaremonitoringservices influencedtheeffectoftheinterventionandthepotentialfor
forthe189patientsunderthecareoftheEdinburghCommunity improvement;wethereforestratifiedrandomisationbyservice
RespiratoryTeamandtheMidlothiannurses.DataforEastand model.Mostparticipantslivedwithin10milesofsecondary
WestLothianserviceswereincompletebecausecarewas carefacilities:outcomesmighthavebeendifferentinruralareas
providedbyanumberofgeneralpracticesandcontactswere wheretelemonitoringmighthavehadagreatereffecton
notrecordedconsistently.Thecommunityteamsdealtwith enhancingaccesstocare.
2441telemonitoringalertsfromthe97telemonitoredpatients
undertheircare,113ofwhichrequiredhomevisits.This
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page6of16
RESEARCH
Blindingofparticipantsandtreatingclinicianswasnotpossible, oflife.38Despitefrequentpromptresponsestochangesin
butcentralrandomisationensuredconcealmentandtheprimary symptomscores,andatrendtoincreasedtreatmentof
outcomewasassessedbytwocliniciansunawareofallocation. exacerbations,wefoundnobenefitinanyoftheseclinical
Toachieveblindingofdatacollection,outcomedatawere outcomes.
collectedbyadifferentmemberoftheresearchteamfromthe Akeyfactorthatcouldincreasethenumberoffalsealertsand
nursewhohadrandomisedthepatients,butweacknowledge limittheeffectivenessoftelemonitoringinCOPDisthelack
thatparticipantscouldhavementionedtelemonitoring,or ofclearearlypredictorsofanexacerbation.39Physiological
equipmentmighthavebeenvisibleduringthehomevisitfor parametershavenotprovedtobesufficientlypredictive.This
datacollection,makingitimpossibletomaintainblindinginall isbecausetheyeitherchangelateinthecourseofthe
cases. exacerbation(forexample,FEV,oxygensaturation,heartrate, 1
temperature)39orcannotbemeasuredreliably(forexample,
Interpretation of findings
respiratoryrate).Developingpredictivealgorithmswith
Ourfindingshighlighttheimportanceofdefiningthenatureof clinicallyusefullevelsofsensitivityandspecificityisthusa
usualcaredeliveredtoacontrolgroupwhenevaluatinga priorityforthefuturedevelopmentoftelemonitoringofCOPD.
complexintervention.Previousstudiesthathaveintroducedan Thesubstantialworkloadgeneratedbythetelemonitoringalerts
enhancedclinicalservicetosupportthetelemonitoringarmof underlinestheimportanceofpilotingandassessingworkforce
atrialhaveachievedimprovedoutcomescomparedwiththe implicationsforbothtechnologicalandclinicalsupportservices
usualcareavailabletopeoplewithCOPD.1012Forexample, duringtheplanningandimplementationphaseof
telemonitoringinthecontextofanintegratedcare reconfiguration.Crucialdecisionsabouteconomiesofscaleand
service31—incorporatingcasemanagement35orproviding therelativeimportanceofcontinuityofcarewillbeneededand
additionalhomevisits36—reducedhospitaladmissions.Similarly, theireffectmonitored.29
intherecentlypublishedWSDtrial,telemonitoringsupported
Logisticalissueswithinstallationbedevilledtheearlymonths
byspecialistcommunitycare,casemanagement,orspecific
oftheinterventionandwillpotentiallyhavereducedany
arrangementswithgeneralpracticesaccordingtolocalservice
effectivenessofourintervention.Fortelemonitoringtobecome
preferenceswascomparedwithusualcare(thatis,withoutthe
mainstream,thetechnologyneedstoadaptseamlesslyto
specificservicesorarrangementsdevelopedtosupportthe
variationsinlocalconnectivityaswellasprovideflexibilityin
telemonitoring).7Inthiscontext,telemonitoringforparticipants
monitoringcapabilitytomeetindividualclinicalneed.Usein
withdiabetes,COPD,orheartfailurewasassociatedwithlower
morespecificcontexts(suchastosupportearlydischargeuntil
ratesofemergencyadmissions,althoughtheauthorsnotedthat theriskofreadmissionhasreceded40)couldthenbepossible.
thedifferencewasduetoashorttermincreaseinemergency
admissionsinthecontrolgroup.7Inourtrial,thesameclinical
Conclusions and implications
servicewasavailabletoparticipantsinbothgroups(albeit
accessedconsiderablymorefrequentlyasaresultofthe Integrationoftelemonitoringintoexistingclinical
telemonitoring)andshowednodifferenceinanyoutcomes.The services—suchthatbothinterventionandcontrolgroupshad
WSDtrialwith3230participantsshowedasignificantreduction accesstothesameclinicalcare—hadnoeffectondelayingtime
inmortality,7bycontrastwithTakahashiandcolleagues,who toahospitaladmission,andhadasubstantialimpacton
foundasubstantialincreaseindeaths.37Ourtrial,however,was workload.Thepositiveeffectoftelemonitoringseeninprevious
notpoweredforthisoutcomeandourestimateofmortalityis trialscouldthusbeduetoenhancementoftheunderpinning
thusimpreciseandcannotcontributetothedebate. clinicalserviceratherthanthetelemonitoringcommunication.
Specificdevelopmentsthatcouldimprovetheperformanceof
Ournestedqualitativestudysuggestedthatpatientswerevery
telemonitoringinCOPDinthefutureincludethevalidationof
positiveaboutthebenefitsoftelemonitoring,162729butthiswas
measuresandalgorithmsthatcanpredictpotentiallyserious
notreflectedbyanimprovementinrespiratory-relatedquality
exacerbationsmorereliably,andanunderstandingofclinical
oflife.Similarly,thelackofchangeintheHADSscore
contextsinwhichtelemonitoringismosteffective.Inthe
suggestedthattheinterventionneitherrelievednorexacerbated
meantime,longtermtelemonitoringofpeoplewithCOPDis overalllevelsofanxietyordepression.Ourtheoretical
unlikelytoreduceadmissionsunlessitisameansofenhancing
frameworkforthetelemonitoringinterventionemphasisedthe
clinicalservices. importanceofempoweringselfmanagement,improving
confidenceofprofessionalsbyprovidingongoingmonitoring
data,andimprovingaccesstoclinicalservices.15Ournested WethankLewisRitchie,Anne-LouiseKinmonth,andChrisGriffithsfor
qualitativedatasuggestedthatcontinuityofcare,29facilitating servingontheindependenttrialsteeringcommittee;WisiaWedzicha
accesstocare,29andsupportingselfmanagement27wereall andJosepRocafortheiradviceascollaborators;alltheprofessionals
inLothianwhoprovidedtheclinicalservice,especiallyAngelaLindsay
perceivedtobeimportantfacetsoftheintervention.However,
(longtermconditionsandtelehealthcarelead)andClairSparriusfrom
thisdidnottranslateintoadifferenceinmeasuredselfefficacy
thecommunityrespiratoryteam;ErinnHadeandGordonMurrayfor
(amediatorofselfmanagement).
providingadditionalstatisticalsupport;theWellcomeTrustClinical
Ourdatadidnotallowustodistinguishtelemonitoringalerts
ResearchFacilityforprovidingcommunityresearchnursing;theScottish
triggeredbyclinicallyconfirmedexacerbationsrequiring
PrimaryCareResearchNetworkforassistancewithparticipant
treatmentfromfalsealarmsthatneedednoadditional
identification;theEdinburghClinicalTrialsUnitfordesigningthetrial
intervention.Weobservedanon-significantincreaseinthe
databaseandprovidingtherandomisationservice;SusanBuckingham
numberofselfreported,treatedexacerbationsinthe
forundertakingqualityassurancechecks;andJenniferHolmesfor
telemonitoringgroup,althoughitisnotclearwhetherthis
providingadministrativesupport.
findingwasduetoimprovedrecognitionofearlyexacerbations
TELESCOTprogrammegroup:BrianMcKinstry,HilaryPinnock,Janet
orovertreatmentof“bad”days.Ourresultschallengeprevious
Hanley,StephanieLewis,AzizSheikh,WilliamMacNee,ClaudiaPagliari,
findingsfromacohortstudyconcludingthatearlyrecognition
ChristineMcClusky,JimForrest,JohnMcKnight,PaulPadfield,Cathie
andtreatmentimprovedexacerbationrecovery,reducedriskof
Sudlow,andSarahWild.
admission,andwasassociatedwithabetterhealthrelatedquality
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page7of16
RESEARCH
Whatisalreadyknownonthistopic
Telemonitoringhasattractedinterestasapotentialsolutiontotheglobalchallengeofprovidingcareforageingpopulationslivingwith
longtermconditionssuchasCOPD
ACochranesystematicreviewoftelemonitoringinCOPDreportedareductioninhospitaladmissionsover12months,although
telemonitoringinthesetrialshadbeensupportedbyenhancedclinicalcarewhichcouldreduceadmissionsinitsownright
ThespecificroleoftelemonitoringinmanagingpeoplewithCOPD,asopposedtotheadditionalclinicalservicescreatedtosupportit,
needstobeclarified
Whatthisstudyadds
Integrationoftelemonitoringintoexistingclinicalservices—suchthatbothinterventionandcontrolgroupshadaccesstothesameclinical
care—didnotdelaytimetoahospitaladmission,andhadasubstantialeffectonworkload
Thepositiveeffectoftelemonitoringseeninprevioustrialscouldbeduetoenhancementoftheunderpinningclinicalserviceratherthan
thetelemonitoringcommunication
LongtermtelemonitoringofpeoplewithCOPDisunlikelytoreduceadmissionsunlessitisaleverforenhancingclinicalservices
Contributors:BMinitiatedtheideaforthestudy,andwithHP,ledthe 9 McKinstryB,PinnockH,SheikhA.TelemedicineformanagementofpatientswithCOPD?
Lancet2009;374:672-3.
developmentoftheprotocol,securingoffunding,studyadministration, 10 McLeanS,NurmatovU,LiuJLY,PagliariC,CarJ,SheikhA.Telehealthcareforchronic
dataanalysis,interpretationofresults,andwritingofthepaper.JH,SL, obstructivepulmonarydisease.CochraneDatabaseSystRev2011;7:CD007718.
11 PolisenaJ,TranK,CimonK,HuttonB,McGillS,PalmerK,etal.Hometelehealthfor
ASh,WM,andCPweregrantholderswhocontributedtodevelopment
chronicobstructivepulmonarydisease:asystematicreviewandmeta-analysis.JTelemed
oftheprotocol,securingoffunding,studyadministration,dataanalysis, Telecare2010;16:120-7.
interpretationofresults,andwritingofthepaper.ATundertookthedata 12 BoltonCE,WatersCS,PeirceS,ElwynG,onbehalfofEPSRCandMRCGrandChallenge
Team.Insufficientevidenceofbenefit:asystematicreviewofhometelemonitoringfor
collection.LMprovidedliaisonbetweentheresearchandclinicalteams, COPD.JEvaluationClinPract2011;17:1216-22.
andprovidedtheregulatoryoversightforthetrial.SLandAKwerethe 13 JaanaM,PareG,SicotteC,Hometelemonitoringforrespiratoryconditions:asystematic
review.AmJManagCare2009;15:313-20.
trialstatisticians.MvdPandAStundertookthehealtheconomicanalysis. 14 BartoliL.ZanaboniP.MasellaC.UrsiniN.Systematicreviewoftelemedicineservices
Allauthorshadfullaccesstoallthedata,andwereinvolvedin forpatientsaffectedbychronicobstructivepulmonarydisease(COPD).TelemedJE
Health2009;15:877-83.
interpretationofthedata.HPandBMwrotetheinitialdraftofthepaper,
15 PinnockH,HanleyJ,LewisS,MacNeeW,PagliariC,vanderPolM,etal.Theimpact
towhichalltheauthorscontributed.HPandBMarestudyguarantors. ofatelemetricchronicobstructivepulmonarydiseasemonitoringservice:randomised
controlledtrialwitheconomicevaluationandnestedqualitativestudy.PrimCareRespir
Competinginterests:AllauthorshavecompletedtheICMJEuniform J2009;18:233-5.
disclosureformatwww.icmje.org/coi_disclosure.pdf(availableon 16 UreJ,HanleyJ,PinnockH,KiddG,McCallSmithE,TarlingA,etal.Piloting
tele-monitoringinchronicobstructivepulmonarydisease:amixedmethodsexploration
requestfromthecorrespondingauthor)anddeclare:supportfromthe ofissuesindesignandimplementation.PrimCareRespirJ2011;21:57-64.
ChiefScientistOfficeoftheScottishgovernmentandNHSLothianfor 17 HurstJR,VestboJ,AnzuetoA,LocantoreN,MüllerovaH,Tal-SingerR,etal.Susceptibility
toexacerbationinchronicobstructivepulmonarydisease.NEnglJMed2010;36:1128-38.
thesubmittedwork;HPissupportedbyaprimarycareresearchcareer
18 BarnettK,MercerSW,NorburyM,WattG,WykeS,GuthrieB.Epidemiologyof
awardfromtheChiefScientist’sOfficeoftheScottishgovernment;BM multimorbidityandimplicationsforhealthcare,research,andmedicaleducation:a
andJHaresupportedviaNHSLothianthroughtheEdinburghHealth cross-sectionalstudy.Lancet2012;380:37-43.
19 GlobalInitiativeforObstructiveLungDisease.GlobalStrategyforthediagnosis,
ServicesResearchUnit;ASissupportedbytheCommonwealthFund, managementandpreventionofchronicobstructivepulmonarydisease.2013.www.
aprivateindependentfoundationbasedinNewYorkCity;noother goldcopd.com.
20 NationalInstituteforClinicalExcellence.Nationalclinicalguidelinemanagementofchronic
relationshipsoractivitiesthatcouldappeartohaveinfluencedthe obstructivepulmonarydiseaseinadultsprimaryandsecondarycare.Thorax2004;59
submittedwork. (suppl1):S1-232.
21 JonesPW,QuirkFH,BaveystockCM,LittlejohnsP.Aself-completemeasureforchronic
Ethicalapproval:EthicalapprovalwasgrantedbytheLothianresearch airflowlimitation-theStGeorge’sRespiratoryQuestionnaire.AmRevRespirDis
ethicscommittee(reference08/S1101/60),andNHSmanagement 1992;145:1321-7.
22 ZigmundAS,SnaithRP.Thehospitalanxietyanddepressionscale.ActaPsychiatrica
approvalwasprovidedbyNHSLothian,Scotland. Scandinavia1983;67:361-70.
Datasharing:Noadditionaldataavailable. 23 LorigKR,Sobel,DS,RitterPL,LaurentD,HobbsM.Effectofaself-managementprogram
forpatientswithchronicdisease.EffectiveClinPract2001;4:256-62.
HPandBMarestudyguarantorsandaffirmthatthemanuscriptisan 24 HylandM,JonesR,HanneyK.TheLungInformationNeedsQuestionnaire:Development,
preliminaryvalidationandfindings.RespirMed2006;100:1807-16.
honest,accurate,andtransparentaccountofthestudybeingreported;
25 HorneR,WeinmanJ.Self-regulationandself-managementinasthma:exploringtherole
thatnoimportantaspectsofthestudyhavebeenomitted;andthatany ofillnessperceptionsandtreatmentbeliefsinexplainingnon-adherencetopreventer
discrepanciesfromthestudyasplanned(and,ifrelevant,registered)
medication.PsychologyHealth2002;17:17-32.
26 BrooksR,RabinR,deCharroF,eds.Themeasurementandvaluationofhealthstatus
havebeenexplained. usingEQ-5D:aEuropeanperspective:evidencefromtheEuroQolBIOMEDresearch
programme.KluwerAcademicPublishers,2003.
27 FairbrotherP,PinnockH,HanleyJ,McCloughanL,SheikhA,PagliariC,etal.Exploring
1 GershonAS,WarnerL,CascagnetteP,VictorJC,ToT.Lifetimeriskofdevelopingchronic telemonitoringandself-managementbypatientswithchronicobstructivepulmonary
obstructivepulmonarydisease:alongitudinalpopulationstudy.Lancet2011;378:991-6. disease:aqualitativestudyembeddedinarandomizedcontrolledtrial.PatEdCounsel 2 LozanoR,NaghaviM,ForemanK,LimS,ShibuyaK,AboyansV,etal.Globalandregional 2013,doi:10.1016/j.pec.2013.04.003.
mortalityfrom235causesofdeathfor20agegroupsin1990and2010:asystematic 28 SeemungalTAR,DonaldsonGC,BhowmikA,JeffriesDJ,WedzichaJA.Timecourse
analysisfortheGlobalBurdenofDiseaseStudy2010.Lancet2012;380:2095-128.
andrecoveryofexacerbationsinpatientswithchronicobstructivepulmonarydisease.
3 VosT,FlaxmanAD,NaghaviM,LozanoR,MichaudC,EzzatiM,etal.Yearslivedwith AmJRespirCritCareMed2000;161:1608-13.
disability(YLDs)for1160sequelaeof289diseasesandinjuries1990-2010:asystematic 29 FairbrotherP,PinnockH,HanleyJ,McCloughanL,SheikhA,PagliariC,etal;onbehalf
analysisfortheGlobalBurdenofDiseaseStudy2010.Lancet2012;380:2163-96. oftheTELESCOTprogrammegroup.Continuity,butatwhatcost?Theimpactof
4 WorldHealthOrganization.2008-2013actionplanfortheglobalstrategyfortheprevention telemonitoringCOPDoncontinuitiesofcare:aqualitativestudy.PrimCareRespirJ
andcontrolofnoncommunicablediseases.WHO,2008. 2012;21:322-8.
5 StroetmannK,KubitschkeL,RobinsonS,StroetmannV,CullenK,McDaidD.EUpolicy 30 BritishLungFoundation.LivingwithCOPD.2013.www.blf.org.uk.
brief13.Howcantelehealthhelpintheprovisionofintegratedcare?WorldHealth 31 CasasA,TroostersT,Garcia-AymerichJ,RocaJ,HernandezC,AlonsoA,etal.Integrated
Organization,2010. carepreventshospitalisationsforexacerbationsinCOPDpatients.EurRespirJ
6 LiddellA,AdsheadS,BurgessE.TechnologyintheNHS:transformingthepatient’s 2006;28:1-8.
experienceofcare.TheKing’sFund,2008. 32 KaplanEL,MeierP.Nonparametricestimationfromincompleteobservations.JAmStatist
7 SteventonA,BardsleyM,BillingsJ,DixonJ,DollH,HiraniS,etal;fortheWholeSystem Assn1958;53:457-81.
DemonstratorEvaluationTeam.Effectoftelehealthonuseofsecondarycareandmortality: 33 CoxDR.Regressionmodelsandlife-tables.JRStatistSocB1972;34:187-220.
findingsfromtheWholeSystemDemonstratorclusterrandomisedtrial.BMJ
34 GudmundssonG,GislasonT,JansonC,LindbergE,HallinR,UlrikCS,etal.Riskfactors
2012;344:e3874. forrehospitalisationinCOPD:roleofhealthstatus,anxietyanddepression.EurRespir
8 HendersonC,KnappM,FernándezJ-L,BeechamJ,HiraniSP,CartwrightM,etal.Cost J2005;26:414-9.
effectivenessoftelehealthforpatientswithlongtermconditions(WholeSystems 35 TrappenburgJCA,NiesinkA,deWeert-vanOeneGH,vanderZeijdenH,vanSnippenburg
Demonstratortelehealthquestionnairestudy):nestedeconomicevaluationinapragmatic, R,PetersA,etal.Effectsoftelemonitoringinpatientswithchronicobstructivepulmonary
clusterrandomisedcontrolledtrial.BMJ2013;346:f1035. disease.TelemedJEHealth2008;14:138-46.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page8of16
RESEARCH
36 VontetsianosT,GiovasP,KatsarasT,RigopoulouA,MpirmpaG,GiaboudakisP,etal. 40 RoyalCollegeofPhysicians,BritishThoracicSociety,andBritishLungFoundation.
Telemedicine-assistedhomesupportforpatientswithadvancedchronicobstructive NationalCOPDResourcesandOutcomesProject.2008.www.brit-thoracic.org.uk/delivery-
pulmonarydisease:preliminaryresultsafternine-monthfollow-up.JTelemedTelecare of-respiratory-care/national-copd-resources-and-outcomes-project.aspx.
2005;11(suppl1):86-8. Accepted:3September2013
37 TakahashiPY,PecinaJL,UpatisingB,ChaudhryR,ShahND,VanHoutenH,etal.A
randomizedcontrolledtrialoftelemonitoringinolderadultswithmultiplehealthissuesto
preventhospitalizationsandemergencydepartmentvisits.ArchInternMed
Citethisas:BMJ2013;347:f6070
2012;172:773-9.
38 WilkinsonTMA,DonaldsonGC,HurstJR,SeemungalTAR,WedzichaJA.Earlytherapy ThisisanOpenAccessarticledistributedinaccordancewiththeCreativeCommons
improvesoutcomesofexacerbationsofchronicobstructivepulmonarydisease.AmJ
AttributionNonCommercial(CCBY-NC3.0)license,whichpermitsotherstodistribute,
RespirCritCareMed2004;169:1298-303.
39 HurstJR,DonaldsonG,QuintJK,GoldringJJP,PatelARC,WedzichaJA,etal.Domiciliary remix,adapt,builduponthisworknon-commercially,andlicensetheirderivativeworks
pulse-oximetryatexacerbationofchronicobstructivepulmonarydisease:prospective ondifferentterms,providedtheoriginalworkisproperlycitedandtheuseis
pilotstudyBMCPulmMed2010;10:52-8. non-commercial.See:http://creativecommons.org/licenses/by-nc/3.0/.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page9of16
RESEARCH
Tables
Table1|Baselinecharacteristicsoftrialparticipants
Telemonitoring(n=128) Control(n=128)
Ageinyears(mean,SD) 69.4(8.8) 68.4(8.4)
Femalesex(Noofparticipants,%) 75(59) 65(51)
FEV %predicted(mean,SD)* 44.0(18.8) 40.0(17.0)
1
GOLDclassificationofseverityofairflowlimitation(Noofparticipants)
Mild/moderate 46 42
Severe 45 42
Verysevere 37 44
MRCdyspnoeascore(Noofparticipants,%)†
1(leastbreathless) 4(3) 1(1)
2 23(18) 26(20)
3 31(24) 27(21)
4 24(19) 31(24)
5(mostbreathless) 45(35) 43(34)
Oneormorecomorbidconditions(Noofparticipants,%) 78(61) 91(71)
NoCOPDadmissionsinpreviousyear(mean,SD)‡ 2.3(2.1) 2.5(2.6)
Smokingstatus(Noofparticipants,%)
Neversmoked 2(2) 0(0)
Ex-smoker 89(70) 98(77)
Currentsmoker 37(29) 30(23)
ScottishIndexofMultipleDeprivation(Noofparticipants,%)§
1(mostdeprived) 39(31) 33(26)
2 36(28) 37(29)
3 26(20) 17(13)
4 9(7) 20(16)
5(leastdeprived) 17(13) 21(16)
Questionnaires(mean,SD)
SGRQ 68.6(16.6) 68.8(15.2)
HADS(anxiety) 9.8(5.2) 9.6(4.6)
Depression 8.9(4.4) 8.2(4.1)
SECD6 5.0(2.2) 5.2(2.3)
MARS 24.0(2.1) 23.8(1.8)
LINQ 7.8(3.3) 7.8(3.4)
SD=standarddeviation;GOLD=GlobalInitiativeforChronicObstructiveLungDisease.
*Telemonitoringn=126,controln=128.
†Telemonitoringn=127,controln=128.
‡Telemonitoringn=127,controln=127.
§Telemonitoringn=127,controln=128.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page10of16
RESEARCH
Table2|Admissionsanddeathsperpatientoveroneyear
Telemonitoring(n=128)* Control(n=128) Adjustedpointestimate(95%CI) P
Timetofirsthospitaladmission(days;median,IQR)
AdmissionwithanexacerbationofCOPD 362(131to>365) 361(113to>365) 0.98(0.66to1.44)† 0.92
AdmissionwithanexacerbationofCOPDordeath 339(131to>365) 287(102to>365) 0.87(0.61to1.27)† 0.46
Noofhospitaladmissions(mean,SD)
AdmissionwithaprimarydiagnosisofCOPDexacerbation 1.2(1.9) 1.1(1.6) 1.10(0.78to1.56) 0.59
AdmissioninwhichCOPDwastheprimaryreasonorafactor 1.5(2.3) 1.3(1.8) 1.14(0.82to1.60) 0.43
intheadmission
Allcauseadmissions 2.2(2.9) 2.0(2.2) 1.08(0.80to1.45) 0.63
Durationofhospitaladmissions(days;mean,SD)
AdmissionwithaprimarydiagnosisofCOPDexacerbation 9.5(19.1) 8.8(15.9) 1.03(0.71to1.50) 0.88
AdmissioninwhichCOPDwastheprimaryreasonorafactor 11.9(22.7) 10.5(18.5) 1.04(0.71to1.51) 0.85
intheadmission
Allcauseadmissions 16.2(27.2) 14.0(20.8) 1.05(0.75to1.48) 0.78
Deaths(No,%) 16(13) 21(16) 0.66(0.29to1.48)‡ 0.31
IQR=interquartilerange;SD=standarddeviation.
*Referencegroup.
†Adjustedhazardratio(95%confidenceinterval)fortimetohospitaladmission.
‡Adjustedoddsratio(95%confidenceinterval)fornumberofdeaths.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page11of16
RESEARCH
Table3|Questionnairedata
Questionnaireandtrialgroup Atbaseline(mean,SD) At12monthsafterrandomisation(mean,SD)
SGRQ*
Telemonitoring(n=105) 67.2(16.6) 68.2(16.3)
Control(n=100) 68.0(16.0) 67.3(17.3)
HADS(anxiety)†
Telemonitoring(n=105) 9.8(5.3) 9.6(5.0)
Control(n=100) 9.4(4.7) 9.1(5.1)
HADS(depression)‡
Telemonitoring(n=105) 8.8(4.3) 9.1(4.6)
Control(n=100) 8.3(4.3) 8.4(4.2)
SECD6§
Telemonitoring(n=105) 5.1(2.1) 5.0(2.2)
Control(n=100) 5.3(2.2) 5.3(2.5)
LINQ¶
Telemonitoring(n=104) 7.9(3.3) 6.9(3.1)
Control(n=96) 7.7(3.5) 6.8(3.6)
MARS**
Telemonitoring(n=104) 24.0(2.0) 24.0(1.7)
Control(n=101) 23.6(1.9) 23.7(1.9)
Dataincludeonlyparticipantswhohadcompleteinformationforeachrespectivequestionnaireatbothtimepoints.Non-completionatoneyearwasduetodeath
(n=37),withdrawalsfromtrial(n=4),andparticipantswhodeclinedtocompletefinalquestionnaires(n=10).
*Measuresrespiratoryhealthrelatedqualityoflifeonascaleof100(greatestimpairment)to0.
†Assessesanxiety:scores≤7arenormal,≥11indicatesignificantanxiety.
‡Assessesdepression:scores≤7arenormal:≥11indicatesignificantdepression.
§Assessesconfidenceinabilitytoselfmanagesymptomsonascaleof1(lowselfefficacy)to10(highselfefficacy).
¶MeasuresinformationneedsofpeoplewithCOPDonascaleof0(lowneeds)to25(highneeds).
**Assessesadherencetotreatmentonascaleof0(lowadherence)to5(highadherence).
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page12of16
RESEARCH
Table4|Logisticsofinstallingtelemonitoringequipmentandtrainingparticipants
Noofdaysorparticipants
Timeperiod(days;mean,SD)
Timefromrandomisationtoinstallationofbroadbandlineandtelemonitoringequipment 56(30)
Timefrominstallationofequipmenttocompletionoftraining 20(21)
Timefromrandomisationtocommencingtelemonitoring 79(48)
Participants
Participantsrandomisedtotelemonitoring 128
Participantsforwhomequipmentwassuccessfullyinstalled 113
Reasonsfornon-installationofequipment:movedtonursinghome,residentialcare,orstayingwithrelatives(n=3);participant —
declined(n=6;fourparticipantswereunhappywithequipmentorinstallationprocess);diedbeforeequipmentwasinstalled(n=2);
participantwastooillwhenequipmentwasduetobeinstalled(n=2);installationwasunsuccessfulortooexpensivetoinstallbroadband
(n=2)
Participantswhoreceivedtraining 109
Reasonsfornotraining:participantdeclinedtrainingandequipmentwaswithdrawn(n=2),participantswastooillwhentrainingwas —
scheduled(n=2),trainingwasunsuccessfulandequipmentwaswithdrawn(n=1)
Participantswhoseequipmentwaswithdrawn 8
Reasonsforwithdrawal:repeatedmalfunctioningofequipment(n=1);participantfeltrestrictedbythehomebasedequipment(n=1); —
onadviceofclinicianbecauseofinconsistentreadings,increasinganxiety(n=3);additionalhealthproblemsmadeuseoftelemonitoring
impossibleorinappropriate(n=4)
SD=standarddeviation.
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page13of16
RESEARCH
Table5|ContactswiththetelemonitoringservicesforpatientsunderthecareoftheEdinburghCommunityRespiratoryTeamandMidlothian
nurses
Telemonitoring(n=97) Control(n=92)
Contactsnotrelatedtoalertsfromtelemonitoring
TotalNoofcontacts
Telephoneconsultations 510 353
Homevisits 821 681
Videolink 2 —
Othercontacts 6 6
Noofcontactsperpatient(mean,SD)
Telephoneconsultations 5.26(4.70) 3.84(5.73)
Homevisits 8.46(8.72) 7.40(7.72)
Videolink 0.02(0.14) —
Othercontacts 0.06(0.24) 0.07(0.29)
Durationofcontacts(minutes;mean,SD)
Telephoneconsultations 6.70(6.82) 7.95(9.71)
Homevisits 33.69(16.02) 34.58(16.13)
Videolink 25.00(7.07) —
Othercontacts 36.67(41.55) 45.00(42.31)
Contactsinresponsetoalertsfromtelemonitoring
Totalnumberofcontacts
Telephoneconsultations 2326 —
Homevisits 113 —
Videolink 0 —
Othercontacts 2 —
Noofcontactsperpatient(mean,SD)
Telephoneconsultations 23.98(22.34) —
Homevisits 1.16(2.02) —
Videolink 0(0) —
Othercontacts 0.02(0.14) —
Durationofcontacts(minutes;mean,SD)
Telephoneconsultations 4.44(3.84) —
Homevisits 28.71(16.99) —
Videolink — —
Othercontacts 4.50(0.71) —
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page14of16
RESEARCH
Figures
Fig1TheLothianCOPDmonitoringsystem.27Reproducedwithpermissionfromreference27
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page15of16
RESEARCH
Fig2Flowofparticipantsthroughthetrial.*Intentiontotreatanalysiscensoredpatientswhodiedorwithdrewbeforea
COPDadmission
Fig3Kaplan-MeiercurvesshowingtimetofirstadmissionwithanexacerbationofCOPD
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
BMJ2013;347:f6070doi:10.1136/bmj.f6070(Published17October2013) Page16of16
RESEARCH
Fig4Subgroupanalysesonprimaryoutcome
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe:http://www.bmj.com/subscribe
BMJ:
first
published
as
10.1136/bmj.f6070
on
17
October
2013.
Downloaded
from
http://www.bmj.com/
on
24
August
2024
by
guest.
Protected
by
copyright.
